4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-042224
Chief Financial Officer sold 30,000 shares at an average $46.87 ($1,406,073)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-07-08 | Option exercise | +30,000 | $6.32 | $189,600 | 31,000 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2020-07-08 | Sale | −27,896 | $46.82 | $1,306,091 | 3,104 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2020-07-08 | Sale | −2,104 | $47.52 | $99,982 | 1,000 | D: show line 3 in the form |
| Open-market sales · 30,000 sh · avg $46.87 · $1,406,073 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-07-08 | Option exercise · Stock Option (Right To Buy) | −30,000 | 640,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…